BioCentury

7:00 AM GMT, Jul 30, 2007
This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.
Strategy

ESA sales

ESA sales

Combined sales of Aranesp darbepoetin alfa, Epogen epoetin alfa and Procrit epoetin alfa grew steadily - about 9% a year -

Read the full 222 word article

This article and the information contained in BioCentury's publications and services are solely for your own personal, non-transferable licensed use and cannot be shared with any other individuals. For information about adding subscribers to your account or obtaining article reprints, please contact support@biocentury.com.